Depression, social support, and beta-adrenergic transcription control in human ovarian cancer

Susan K. Lutgendorf, Koenraad De Geest, Caroline Y. Sung, Jesusa M. Arevalo, Frank Penedo, Joseph Lucci, Michael Goodheart, David Lubaroff, Donna M. Farley, Anil K. Sood, Steve W. Cole

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Motivated by previous indications that beta-adrenergic signaling can regulate tumor cell gene expression in model systems, we sought to determine whether similar dynamics occur in primary human ovarian cancer. DNA microarray analyses of 10 ovarian carcinomas identified 266 human transcripts that were differentially expressed in tumors from patients with elevated biobehavioral risk factors (high depressive symptoms and low social support) relative to grade- and stage-matched tumors from low-risk patients. Promoter-based bioinformatic analyses indicated increased activity of several beta-adrenergically-linked transcription control pathways, including CREB/ATF, NF-κB/Rel, STAT, and Ets family transcription factors. Consistent with increased beta-adrenergic signaling, high biobehavioral risk patients also showed increased intra-tumor concentrations of norepinephrine (but no difference in plasma norepinephrine). These data show that genome-wide transcriptional profiles are significantly altered in tumors from patients with high behavioral risk profiles, and they identify beta-adrenergic signal transduction as a likely mediator of those effects.

Original languageEnglish (US)
Pages (from-to)176-183
Number of pages8
JournalBrain, Behavior, and Immunity
Volume23
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

Social Support
Adrenergic Agents
Ovarian Neoplasms
Depression
Neoplasms
Norepinephrine
Proto-Oncogene Proteins c-ets
Microarray Analysis
Oligonucleotide Array Sequence Analysis
Computational Biology
Signal Transduction
Genome
Carcinoma
Gene Expression

Keywords

  • Beta-adrenergic receptor
  • Gene expression
  • Ovarian cancer
  • Sympathetic nervous system
  • Transcription factor

ASJC Scopus subject areas

  • Immunology
  • Behavioral Neuroscience
  • Endocrine and Autonomic Systems

Cite this

Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. / Lutgendorf, Susan K.; De Geest, Koenraad; Sung, Caroline Y.; Arevalo, Jesusa M.; Penedo, Frank; Lucci, Joseph; Goodheart, Michael; Lubaroff, David; Farley, Donna M.; Sood, Anil K.; Cole, Steve W.

In: Brain, Behavior, and Immunity, Vol. 23, No. 2, 02.2009, p. 176-183.

Research output: Contribution to journalArticle

Lutgendorf, SK, De Geest, K, Sung, CY, Arevalo, JM, Penedo, F, Lucci, J, Goodheart, M, Lubaroff, D, Farley, DM, Sood, AK & Cole, SW 2009, 'Depression, social support, and beta-adrenergic transcription control in human ovarian cancer', Brain, Behavior, and Immunity, vol. 23, no. 2, pp. 176-183. https://doi.org/10.1016/j.bbi.2008.04.155
Lutgendorf, Susan K. ; De Geest, Koenraad ; Sung, Caroline Y. ; Arevalo, Jesusa M. ; Penedo, Frank ; Lucci, Joseph ; Goodheart, Michael ; Lubaroff, David ; Farley, Donna M. ; Sood, Anil K. ; Cole, Steve W. / Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. In: Brain, Behavior, and Immunity. 2009 ; Vol. 23, No. 2. pp. 176-183.
@article{da2244696f264eeab058643a28085ac3,
title = "Depression, social support, and beta-adrenergic transcription control in human ovarian cancer",
abstract = "Motivated by previous indications that beta-adrenergic signaling can regulate tumor cell gene expression in model systems, we sought to determine whether similar dynamics occur in primary human ovarian cancer. DNA microarray analyses of 10 ovarian carcinomas identified 266 human transcripts that were differentially expressed in tumors from patients with elevated biobehavioral risk factors (high depressive symptoms and low social support) relative to grade- and stage-matched tumors from low-risk patients. Promoter-based bioinformatic analyses indicated increased activity of several beta-adrenergically-linked transcription control pathways, including CREB/ATF, NF-κB/Rel, STAT, and Ets family transcription factors. Consistent with increased beta-adrenergic signaling, high biobehavioral risk patients also showed increased intra-tumor concentrations of norepinephrine (but no difference in plasma norepinephrine). These data show that genome-wide transcriptional profiles are significantly altered in tumors from patients with high behavioral risk profiles, and they identify beta-adrenergic signal transduction as a likely mediator of those effects.",
keywords = "Beta-adrenergic receptor, Gene expression, Ovarian cancer, Sympathetic nervous system, Transcription factor",
author = "Lutgendorf, {Susan K.} and {De Geest}, Koenraad and Sung, {Caroline Y.} and Arevalo, {Jesusa M.} and Frank Penedo and Joseph Lucci and Michael Goodheart and David Lubaroff and Farley, {Donna M.} and Sood, {Anil K.} and Cole, {Steve W.}",
year = "2009",
month = "2",
doi = "10.1016/j.bbi.2008.04.155",
language = "English (US)",
volume = "23",
pages = "176--183",
journal = "Brain, Behavior, and Immunity",
issn = "0889-1591",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Depression, social support, and beta-adrenergic transcription control in human ovarian cancer

AU - Lutgendorf, Susan K.

AU - De Geest, Koenraad

AU - Sung, Caroline Y.

AU - Arevalo, Jesusa M.

AU - Penedo, Frank

AU - Lucci, Joseph

AU - Goodheart, Michael

AU - Lubaroff, David

AU - Farley, Donna M.

AU - Sood, Anil K.

AU - Cole, Steve W.

PY - 2009/2

Y1 - 2009/2

N2 - Motivated by previous indications that beta-adrenergic signaling can regulate tumor cell gene expression in model systems, we sought to determine whether similar dynamics occur in primary human ovarian cancer. DNA microarray analyses of 10 ovarian carcinomas identified 266 human transcripts that were differentially expressed in tumors from patients with elevated biobehavioral risk factors (high depressive symptoms and low social support) relative to grade- and stage-matched tumors from low-risk patients. Promoter-based bioinformatic analyses indicated increased activity of several beta-adrenergically-linked transcription control pathways, including CREB/ATF, NF-κB/Rel, STAT, and Ets family transcription factors. Consistent with increased beta-adrenergic signaling, high biobehavioral risk patients also showed increased intra-tumor concentrations of norepinephrine (but no difference in plasma norepinephrine). These data show that genome-wide transcriptional profiles are significantly altered in tumors from patients with high behavioral risk profiles, and they identify beta-adrenergic signal transduction as a likely mediator of those effects.

AB - Motivated by previous indications that beta-adrenergic signaling can regulate tumor cell gene expression in model systems, we sought to determine whether similar dynamics occur in primary human ovarian cancer. DNA microarray analyses of 10 ovarian carcinomas identified 266 human transcripts that were differentially expressed in tumors from patients with elevated biobehavioral risk factors (high depressive symptoms and low social support) relative to grade- and stage-matched tumors from low-risk patients. Promoter-based bioinformatic analyses indicated increased activity of several beta-adrenergically-linked transcription control pathways, including CREB/ATF, NF-κB/Rel, STAT, and Ets family transcription factors. Consistent with increased beta-adrenergic signaling, high biobehavioral risk patients also showed increased intra-tumor concentrations of norepinephrine (but no difference in plasma norepinephrine). These data show that genome-wide transcriptional profiles are significantly altered in tumors from patients with high behavioral risk profiles, and they identify beta-adrenergic signal transduction as a likely mediator of those effects.

KW - Beta-adrenergic receptor

KW - Gene expression

KW - Ovarian cancer

KW - Sympathetic nervous system

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=58849143843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849143843&partnerID=8YFLogxK

U2 - 10.1016/j.bbi.2008.04.155

DO - 10.1016/j.bbi.2008.04.155

M3 - Article

C2 - 18550328

AN - SCOPUS:58849143843

VL - 23

SP - 176

EP - 183

JO - Brain, Behavior, and Immunity

JF - Brain, Behavior, and Immunity

SN - 0889-1591

IS - 2

ER -